A study of dulaglutide for children with type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if a weekly injection of dulaglutide (Trulicity) can help children with type 2 diabetes control their blood sugar when used together with metformin and/or insulin. It may be an option for kids who are overweight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes and are 18 or younger (child or teen).
- You have been taking metformin and/or long-acting insulin for at least 8 weeks without changing the dose.
- You weigh at least 110 pounds (50 kg) and your BMI is in the 85th percentile or higher for your age and sex.
- You have NOT had diabetic ketoacidosis or a very high blood sugar crisis after your diabetes diagnosis.
- You have not used any other diabetes medicines (besides metformin, long-acting insulin, or dulaglutide) in the past 8 weeks.
- You have no history of severe low blood sugar (hypoglycemia) or loss of awareness of low blood sugar in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if adding LY3457263 helps lower blood sugar in people with type 2 diabetes who are already taking a stable dose of semaglutide or tirzepatide. You will be randomly assigned to get either LY3457263 or a placebo.
This study tests a new medicine called HS-20094 for people with type 2 diabetes. It aims to see if it helps lower blood sugar and may also help with weight. You may be able to join if you are currently on metformin or metformin plus an SGLT-2 inhibitor.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This study tests an investigational shot (given every two weeks) that may help lower blood sugar in people with type 2 diabetes. Participation involves regular check-ups and blood tests to see how well the treatment works for you.
This study tests an experimental daily pill (orforglipron) against an approved weekly injection (dulaglutide) in young people with type 2 diabetes. It aims to see which works better at controlling blood sugar and may offer a more convenient option.
This Phase 2 trial tests a weekly GLP-1 medicine (dulaglutide) to improve blood sugar control in adults with cystic fibrosis (CF) who have trouble managing glucose. It may help people with CF-related prediabetes or diabetes by improving how their body handles sugar.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.